Gene Synthesis Market (By Method: Solid-phase synthesis, Chip- based synthesis, PCR- based Enzyme synthesis; By Service: Antibody DNA synthesis, Viral DNA synthesis, Others; By Application: Gene & cell therapy development, Vaccine development, Diseases diagnosis, Others; By End Users: Biotechnology & pharmaceutical companies, Academic & government research institutes, Contract research organizations) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Gene Synthesis Market 

5.1. COVID-19 Landscape: Gene Synthesis Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Gene Synthesis Market, By Method

8.1. Gene Synthesis Market, by Method, 2023-2032

8.1.1. Solid-phase synthesis

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Chip- based synthesis

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. PCR- based Enzyme synthesis

8.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Gene Synthesis Market, By Service

9.1. Gene Synthesis Market, by Service, 2023-2032

9.1.1. Antibody DNA synthesis

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Viral DNA synthesis

9.1.2.1. Market Revenue and Forecast (2021-2032)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Gene Synthesis Market, By Application 

10.1. Gene Synthesis Market, by Application, 2023-2032

10.1.1. Gene & cell therapy development

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Vaccine development

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Diseases diagnosis

10.1.3.1. Market Revenue and Forecast (2021-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Gene Synthesis Market, By End Users 

11.1. Gene Synthesis Market, by End Users, 2023-2032

11.1.1. Biotechnology & pharmaceutical companies

11.1.1.1. Market Revenue and Forecast (2021-2032)

11.1.2. Academic & government research institutes

11.1.2.1. Market Revenue and Forecast (2021-2032)

11.1.3. Contract research organizations

11.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global Gene Synthesis Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Method (2021-2032)

12.1.2. Market Revenue and Forecast, by Service (2021-2032)

12.1.3. Market Revenue and Forecast, by Application (2021-2032)

12.1.4. Market Revenue and Forecast, by End Users (2021-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Method (2021-2032)

12.1.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.1.5.4. Market Revenue and Forecast, by End Users (2021-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Method (2021-2032)

12.1.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.1.6.4. Market Revenue and Forecast, by End Users (2021-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Method (2021-2032)

12.2.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.4. Market Revenue and Forecast, by End Users (2021-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Method (2021-2032)

12.2.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.5.4. Market Revenue and Forecast, by End Users (2021-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Method (2021-2032)

12.2.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.6.4. Market Revenue and Forecast, by End Users (2021-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Method (2021-2032)

12.2.7.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.7.4. Market Revenue and Forecast, by End Users (2021-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Method (2021-2032)

12.2.8.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.8.4. Market Revenue and Forecast, by End Users (2021-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Method (2021-2032)

12.3.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.4. Market Revenue and Forecast, by End Users (2021-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Method (2021-2032)

12.3.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.5.4. Market Revenue and Forecast, by End Users (2021-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Method (2021-2032)

12.3.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.6.4. Market Revenue and Forecast, by End Users (2021-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Method (2021-2032)

12.3.7.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.7.4. Market Revenue and Forecast, by End Users (2021-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Method (2021-2032)

12.3.8.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.8.4. Market Revenue and Forecast, by End Users (2021-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Method (2021-2032)

12.4.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.4. Market Revenue and Forecast, by End Users (2021-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Method (2021-2032)

12.4.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.5.4. Market Revenue and Forecast, by End Users (2021-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Method (2021-2032)

12.4.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.6.4. Market Revenue and Forecast, by End Users (2021-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Method (2021-2032)

12.4.7.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.7.4. Market Revenue and Forecast, by End Users (2021-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Method (2021-2032)

12.4.8.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.8.4. Market Revenue and Forecast, by End Users (2021-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Method (2021-2032)

12.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.5.4. Market Revenue and Forecast, by End Users (2021-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Method (2021-2032)

12.5.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.5.5.4. Market Revenue and Forecast, by End Users (2021-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Method (2021-2032)

12.5.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.5.6.4. Market Revenue and Forecast, by End Users (2021-2032)

Chapter 13. Company Profiles

13.1. OriGene Technologies,Inc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Integrated DNA Technologies, Inc

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Thermo Fisher Scientific, Inc

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. ProMab Biotechnologies, Inc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Eurofins Scientific

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Biomatik

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. ProteoGenix

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Bosyer Biological Technology

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. GenScript

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Brooks Automation, Inc

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample